GlassScriptPhysician profile
Samer Homsi
NPI 1366604902
$9,410.38
in general payments reported to CMS, 2019-2025
34 companies · $2,397 in 2025
The $2,397 reported for 2025 was more than what 79% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.15 · 2020: $567 · 2021: $688 · 2022: $1,584 · 2023: $2,042 · 2024: $2,076 · 2025: $2,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,418 · Education: $97.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,417.68 |
| Education | $97.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,195.53 | 2020-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,789.19 | 2020-2025 | Fasenra, Tezspire, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,025.62 | 2020-2025 | Ofev, Stiolto Respimat, Jascayd |
| Mallinckrodt Hospital Products INC. | $537.89 | 2020-2025 | Acthar |
| Electromed, INC. | $520.59 | 2024-2025 | Smartvest |
| Genzyme Corporation | $431.55 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $294.37 | 2020-2025 | Glassia |
| Harmony Biosciences LLC | $280.05 | 2023-2025 | Wakix |
| Regeneron Healthcare Solutions, INC. | $252.10 | 2022-2025 | Dupixent |
| Mylan Specialty L.P. | $238.54 | 2022-2024 | Yupelri |
| United Therapeutics Corporation | $212.00 | 2019-2025 | Tyvaso |
| Insmed, INC. | $194.91 | 2023-2025 | Arikayce, Brinsupri |
| Baxter Healthcare | $194.48 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Merck Sharp & Dohme LLC | $142.83 | 2025 | Zerbaxa |
| Viatris Specialty LLC | $123.19 | 2025 | Yupelri |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $121.26 | 2020-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Ani Pharmaceuticals, INC. | $99.54 | 2022-2025 | Purified Cortrophin Gel |
| Genentech USA, INC. | $97.23 | 2020-2025 | Xolair |
| Sanofi-Aventis U.S. LLC | $78.99 | 2024 | |
| Amgen INC. | $77.84 | 2023-2024 | Tezspire, Tavneos |
| Verona Pharma, INC. | $71.55 | 2025 | Ohtuvayre |
| Inspire Medical Systems, INC. | $52.23 | 2024 | Inspire |
| Csl Behring | $51.76 | 2020 | |
| Grifols USA, LLC | $50.32 | 2021-2022 | |
| Vifor Pharma, INC. | $49.79 | 2024-2025 | Zemaira |
| Intuitive Surgical, INC. | $46.33 | 2024 | |
| Mallinckrodt Enterprises LLC | $33.95 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.70 | 2021 | |
| Advanced Respiratory, INC | $29.21 | 2020-2021 | |
| Inogen, INC. | $22.33 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $18.07 | 2020 | |
| 3b Medical, INC. | $16.74 | 2025 | Luna |
| Erbe USA INC | $15.64 | 2025 | Cryo2 |
| Idorsia Pharmaceuticals US INC | $15.06 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samer Homsi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.